Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi B Haas

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Adoptive Cellular Therapy for Solid TumorsAdham S Bear, Joseph A Fraietta, Vivek K Narayan, et al.
The Journal of Urology|August 22, 2018
Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 TrialVivek Narayan, Maneka Puligandla, Naomi B Haas, et al.
Cancer|June 28, 2007
Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology GroupRobert Dreicer, Shuli Li, Judith Manola, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2023
Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting?Catherine C Fahey, Jeffrey W Shevach, Ronan Flippot, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 7, 2018
Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805Ryne Estabrook, David Cella, Fengmin Zhao, et al.
Clinical Genitourinary Cancer|May 3, 2023
Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United StatesYizhen Lai, Arielle G Bensimon, Emily Gao, et al.
Cancer|January 9, 2019
Association between age and sex and mortality after adjuvant therapy for renal cancerRonac Mamtani, Xin Victoria Wang, Bishal Gyawali, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2012
Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSAJoanne W Jang, Wei-Ting Hwang, Thomas J Guzzo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2011
Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancerSamuel Swisher-McClure, Craig E Pollack, John P Christodouleas, et al.
Cancer Medicine|June 3, 2024
Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groupsJose A Karam, Rituparna Bhattacharya, Adesuwa Ogbomo, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Adoptive Cellular Therapy for Solid TumorsAdham S Bear, Joseph A Fraietta, Vivek K Narayan, et al.
The Journal of Urology|August 22, 2018
Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 TrialVivek Narayan, Maneka Puligandla, Naomi B Haas, et al.
Cancer|June 28, 2007
Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology GroupRobert Dreicer, Shuli Li, Judith Manola, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2023
Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting?Catherine C Fahey, Jeffrey W Shevach, Ronan Flippot, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 7, 2018
Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805Ryne Estabrook, David Cella, Fengmin Zhao, et al.
Clinical Genitourinary Cancer|May 3, 2023
Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United StatesYizhen Lai, Arielle G Bensimon, Emily Gao, et al.
Cancer|January 9, 2019
Association between age and sex and mortality after adjuvant therapy for renal cancerRonac Mamtani, Xin Victoria Wang, Bishal Gyawali, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2012
Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSAJoanne W Jang, Wei-Ting Hwang, Thomas J Guzzo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2011
Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancerSamuel Swisher-McClure, Craig E Pollack, John P Christodouleas, et al.
Cancer Medicine|June 3, 2024
Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groupsJose A Karam, Rituparna Bhattacharya, Adesuwa Ogbomo, et al.
Pageof 11